v3.22.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value, assets and liabilities measured on recurring basis The following table summarize the assets and liabilities measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021.
March 31, 2022
Level 1Level 2Level 3Total
Financial Assets
Short term investments
Corporate Bonds$13,776 $— $— $13,776 
Treasury Bonds$7,445 $— $— $7,445 
Asset Backed Securities$— $5,261 $— $5,261 
Other$586 $— $— $586 
Financial Liabilities
Contingent Consideration$— $— $31,480 $31,480 
December 31, 2021
Level 1Level 2Level 3Total
Financial Assets
Short term investments
Corporate Bonds$22,476 $— $— $22,476 
Treasury Bonds$14,317 $— $— $14,317 
Asset Backed Securities$— $8,272 $— $8,272 
Other$837 $— $— $837 
Financial Liabilities
Contingent Consideration$— $— $28,910 $28,910 
Schedule of fair value, liabilities measured on recurring basis, unobservable input reconciliation The following table summarizes the change in fair value of Level 3 instruments in 2022:
Total
Balance at January 1, 2022
$28,910 
Change in fair value of contingent consideration2,570 
Balance at March 31, 2022
$31,480 
Schedule of fair value measurement inputs and valuation techniques
The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of March 31, 2022 and December 31, 2021:
March 31, 2022December 31, 2021
Valuation techniquesDiscounted cash flow, Monte Carlo
Present value discount rate(1)
19.3 %18.4 %
Volatility factor46.5 %50.3 %
Expected years2.1 years2.4 years

(1) The present value discount rate includes estimated risk premium.